Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4110/in.2021.21.e7 http://scihub22266oqcxt.onion/10.4110/in.2021.21.e7 33728100!7937511!33728100     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Immune+Netw 2021 ; 21 (1): e7 Nephropedia Template TP {{tp|p=33728100|t=2021. COVID-19 Antiviral and Treatment Candidates: Current Status |pdf=|usr=}}{{33728100}} gab.com Text COVID-19 Antiviral and Treatment Candidates: Current Status JO: Immune Netw http://www.kidney.de/pget.php?&tw=1&pmid=33728100 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 has severely impacted global health and economy. There is currently no effective approved treatment for COVID-19; although vaccines have been granted emergency use authorization in several countries, they are currently only administered to high-risk individuals, thereby leaving a gap in virus control measures. The scientific and clinical communities and drug manufacturers have collaborated to speed up the discovery of potential therapies for COVID-19 by taking advantage of currently approved drugs as well as investigatory agents in clinical trials. In this review, we stratified some of these candidates based on their potential targets in the progression of COVID-19 and discuss some of the results of ongoing clinical evaluations. Twit Text FOAVip COVID-19 Antiviral and Treatment Candidates: Current Status ????Immune Netw http://www.kidney.de/pget.php?&tw=1&pmid=33728100 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33728100 #FOAvip English Wikipedia <ref>{{Cite pmid|33728100}}</ref> COVID-19 Antiviral and Treatment Candidates: Current Status #MMPMID33728100 Espano E; Kim D; Kim J; Park SK; Kim JK Immune Netw 2021[Feb]; 21 (1): e7 PMID33728100show ga The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 has severely impacted global health and economy. There is currently no effective approved treatment for COVID-19; although vaccines have been granted emergency use authorization in several countries, they are currently only administered to high-risk individuals, thereby leaving a gap in virus control measures. The scientific and clinical communities and drug manufacturers have collaborated to speed up the discovery of potential therapies for COVID-19 by taking advantage of currently approved drugs as well as investigatory agents in clinical trials. In this review, we stratified some of these candidates based on their potential targets in the progression of COVID-19 and discuss some of the results of ongoing clinical evaluations. äCOVID-19 Antiviral and Treatment Candidates: Current Status (epmc).pdf DeepDyve Pubget Overpricing